ISRCTN74608958
Completed
未知
Assessment of a topical skin protectant (barrier cream) for the prevention and treatment of incontinence-associated dermatitis (IAD).
Bracco Healthcare (USA)0 sites32 target enrollmentStarted: May 4, 2012Last updated:
Overview
- Phase
- 未知
- Status
- Completed
- Sponsor
- Bracco Healthcare (USA)
- Enrollment
- 32
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1\. Age \>17 years
- •2\. Generally healthy
- •3\. Willing to attend up to three, five day sessions
Exclusion Criteria
- •1\. Dark\-skinned volunteers. (This is because darker skin may affect some of the measurements we intend to make, as our instruments rely on being able to detect changes in skin colour and blood flow. The presence of melanin (the substance responsible for darkening the skin) reduces the sensitivity of our equipment. This will not affect the outcome of our study ? if the treatment is successful, it will work on all skin types.)
- •2\. Pre\-existing skin disease such as eczema, dermatitis or skin allergy
- •3\. Concurrent use of aspirin, paracetamol or any other anti\-inflammatory drugs
Investigators
Similar Trials
Completed
Not Applicable
Efficacy of a skin protecting cream in skin barrier protection and repairNL-OMON38880Academisch Medisch Centrum170
Completed
Not Applicable
To test the safety of 3 test products for skin irritatioCTRI/2020/08/027431Sun Pharmaceutical Industries Ltd56
Completed
Not Applicable
To test the safety of 3 test products for skin irritatioCTRI/2021/03/032023Sun Pharmaceutical Industries Ltd56
Completed
Not Applicable
To evaluate safety of 3c test products for skin irritation.CTRI/2021/08/035395Sun Pharmaceutical Industries Ltd53
Completed
Not Applicable
To evaluate safety of a test product for skin irritatioCTRI/2021/03/032171Om Sai Pharma Pack56